Category: Press Releases

Posted on

Liquid Instruments Lança Moku:Pro – Uma Plataforma de Instrumentação de Alto Desempenho Definida por Software para Engenheiros e Cientistas

Nova arquitetura proporciona nove instrumentos com capacidades de medição em tempo real para laboratórios de pesquisa

CANBERRA, Austrália e SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) — A Liquid Instruments, empresa inovadora em instrumentação definida por software de precisão, anunciou hoje o lançamento do Moku:Pro, uma plataforma de alto desempenho para laboratórios de engenharia e pesquisa.

O Moku:Pro acelera a transição do hardware tradicional de teste e medição de função fixa para uma abordagem flexível com base em field-programmable gate array (matriz de portas programáveis em campo – FPGA), tornando os instrumentos de alta qualidade acessíveis em uma plataforma integrada e atualizável por software.MokuPro-Digital

“Os pesquisadores em engenharia e física enfrentam exigências em constante evolução – com mudanças ocorrendo em um tempo muito menor do que a vida útil do equipamento de teste”, disse Daniel Shaddock, CEO da Liquid Instruments. “A arquitetura de hardware habilitado por software do Moku:Pro permite que ele evolua juntamente com suas aplicações, o que não é possível com equipamentos de teste convencionais.”

O Moku:Pro hospeda nove instrumentos potentes, incluindo osciloscópio, amplificador de bloqueio, controlador PID, fasímetro, gerador de forma de onda arbitrária, registrador de dados, analisador de espectro, analisador de resposta de frequência e gerador de forma de onda para garantir que os pesquisadores tenham a instrumentação necessária para caracterizar rapidamente sua configuração e dimensionar seus experimentos. A plataforma foi projetada para atender às necessidades dos pesquisadores em uma variedade de campos, do aeroespacial ao semicondutor. O conjunto de instrumentos do Moku:Pro é particularmente adequado para aplicações fotônicas, incluindo espectroscopia, microscopia, metrologia, detecção de ondas gravitacionais, estabilização a laser ativa e computação quântica.

“A computação quântica aumenta os limites do desempenho da eletrônica, óptica e processamento flexível de sinais em tempo real. A instrumentação definida por software é o futuro dos sistemas de teste e medição para computação quântica”, disse Andrew Horsley, CEO e cofundador da Quantum Brilliance, uma empresa de computação quântica completa que trabalha com tecnologia de diamante em temperatura ambiente.  “O Moku:Pro é a base de um laboratório e uma das ferramentas fotônicas mais versáteis que já vimos.”

Instrumentação na Era Moderna
O Moku:Pro leva o teste e a medição para a era moderna, permitindo que engenheiros e pesquisadores alternem dinamicamente entre os instrumentos em vez de precisarem de vários dispositivos autônomos.  A tecnologia avançada de mistura de ADC garante que cada instrumento possa funcionar com sensibilidade ideal desde a FR até as frequências acústicas sem comprometer o desempenho da flexibilidade. A conectividade total via Wi-Fi, Ethernet e USB-C garante a configuração sem problemas padrão da indústria.MokuPro-Digital 2

Um benefício fundamental da instrumentação definida por software é que ela melhora ao longo do tempo. O Moku:Pro pode ser atualizado aereamente, podendo fornecer especificações melhoradas, novos instrumentos ou recursos totalmente novos. Esses benefícios devem estar disponíveis para os usuários em setembro, quando a Liquid Instruments pretende lançar um recurso que dará ao Moku:Pro a capacidade de executar vários instrumentos em conjunto e trocar automaticamente os instrumentos. Neste modo multi-instrumento, os instrumentos podem ser combinados e conectados para formar dutos sofisticados de processamento de sinal. Em setembro também estamos planejando lançar nova ferramenta com base na nuvem que permitirá que os usuários programem diretamente o FPGA do Moku:Pro. Com essa capacidade, os usuários poderão implementar algoritmos de processamento de sinal exclusivos e criar seus próprios instrumentos personalizados, ampliando ainda mais a lacuna com o hardware convencional.

Especificações do Moku:Pro

  • 4 entradas e saídas analógicas
  • Entrada ADC combinada (10 bits+18 bits) para aplicações de baixo ruído e alta largura de banda
  • Taxa de amostragem de 5 GSa/s (1 canal), 1,25 GSa/s (4 canais)
  • 9 instrumentos integrados, incluindo um amplificador de bloqueio DC-600 MHz
  • SSD de 120 GB para armazenamento a bordo de alta velocidade
  • Suporte de API para Python e MATLAB
  • Configuração base a partir de US$ 12.000, suíte completa de até US$ 20.000.

Uma História de Sucesso
A equipe de liderança técnica da Liquid Instruments tem expertise em medições complexas na Australian National University, Max Planck Institute, Lockheed Martin, Caltech e Laboratório de Propulsão a Jato da NASA.  O Moku:Pro expande a linha de soluções definidas por software da Moku:Lab, uma plataforma de doze instrumentos para pesquisa e, mais recentemente, Moku:Go, uma solução de laboratório completa e portátil para o ensino de graduação.

Para mais informação sobre o Moku:Pro, visite:

Sobre a Liquid Instruments
A Liquid Instruments é líder em instrumentação definida por software de precisão e está revolucionando a maneira como estudantes, engenheiros e cientistas aprendem, trabalham e descobrem. Sua linha de produtos de soluções de hardware e software aproveita a capacidade computacional dos FPGAs modernos para criar instrumentação altamente personalizável para o controle de experimentos, aquisição e análise de dados. O hardware definido por IP no software da equipe permite que os produtos Moku sejam reconfiguráveis dinamicamente em campo, atendendo a uma ampla gama de situações experimentais e de controle de processos em constante mudanças. Para mais informação, visite https://liquidinstruments.com.

O Projeto recebeu financiamento do Governo Australiano. A Liquid Instruments agradece o financiamento e o apoio do Governo Australiano no programa CRC-P administrado pelo Departamento de Inovação e Ciência da Indústria.

Contato com a Mídia
Codeword em nome da Liquid Instruments
liquidinstruments@codewordagency.com
801-703-4092

Fotos deste comunicado podem ser encontradas em

https://www.globenewswire.com/NewsRoom/AttachmentNg/37cb06a3-2242-4fe9-b6d2-0243a826051f

https://www.globenewswire.com/NewsRoom/AttachmentNg/8e84cd5f-7bf1-4276-9950-f57a12cfac19

Posted on

Liquid Instruments lance Moku:Pro, une plateforme d’instrumentation définie par logiciel à hautes performances destinée aux ingénieurs et aux scientifiques

La nouvelle architecture fournit neuf instruments avec des capacités de mesure en temps réel aux laboratoires de recherche

CANBERRA, Australie et SAN DIEGO, 23 juin 2021 (GLOBE NEWSWIRE) — Liquid Instruments, un innovateur spécialisé dans les instruments de précision définis par logiciel, a présenté aujourd’hui Moku:Pro, une plateforme de haute performance pour les laboratoires d’ingénierie et de recherche.

Moku:Pro accélère la transition du matériel de mesure et de test à fonction fixe traditionnel vers une approche flexible basée sur les FPGA (Field Programmable Gate Arrays ou réseaux logiques programmables) en rendant les instruments de haute qualité accessibles au sein d’une plateforme intégrée évolutive par logiciel.

« Les chercheurs en ingénierie et physique font face à des exigences en constante évolution, avec des changements survenant selon des délais beaucoup plus courts que la durée de vie des équipements de test », a déclaré Daniel Shaddock, PDG de Liquid Instruments. « L’architecture matérielle compatible logiciel de Moku:Pro lui permet d’évoluer en même temps que vos applications, ce qui est tout simplement impossible avec les équipements de test conventionnels. »MokuPro-Digital

Moku:Pro contient neuf instruments puissants, dont un oscilloscope, un amplificateur à détection synchrone, un régulateur PID, un phasemètre, un générateur de forme d’onde arbitraire, un enregistreur de données, un analyseur de spectre, un analyseur de courbes de fréquence et un générateur d’onde pour s’assurer que les chercheurs disposent des instruments dont ils ont besoin pour caractériser et adapter rapidement leurs expériences. La plateforme a été conçue pour répondre aux besoins des chercheurs dans divers domaines, de l’aéronautique aux semi-conducteurs. La suite d’instruments de Moku:Pro est particulièrement adaptée aux applications photoniques, y compris la spectroscopie, la microscopie, la métrologie, la détection des ondes gravitationnelles, la stabilisation laser active et l’informatique quantique.

« L’informatique quantique repousse les limites de performance de l’électronique, de l’optique et du traitement flexible des signaux en temps réel. Nous considérons l’instrumentation définie par logiciel comme l’avenir des systèmes de test et de mesure pour l’informatique quantique », a déclaré Andrew Horsley, PDG et cofondateur de Quantum Brilliance, une société spécialisée dans l’informatique quantique full-stack travaillant sur la technologie des diamants à température ambiante.« Moku:Pro est un cheval de bataille du laboratoire et l’un des outils photoniques les plus polyvalents que nous ayons vus. »

Intégrer l’instrumentation à l’ère moderne
Moku:Pro fait entrer les tests et les mesures dans l’ère moderne, permettant aux ingénieurs et aux chercheurs de basculer dynamiquement entre les instruments plutôt que d’avoir besoin de plusieurs appareils autonomes. La technologie avancée de mélange ADC garantit que chaque instrument peut fonctionner avec une sensibilité optimale des fréquences RF aux fréquences acoustiques sans compromettre les performances de flexibilité. La connectivité complète via Wi-Fi, Ethernet et USB-C garantit une configuration standard et sans tracas.MokuPro-Digital 2

L’un des principaux avantages de l’instrumentation définie par logiciel est qu’elle s’améliore au fil du temps. Moku:Pro peut recevoir des mises à jour par liaison radio pour fournir des spécifications améliorées, de nouveaux instruments ou des capacités entièrement nouvelles. Les utilisateurs peuvent s’attendre à voir ces avantages dès le mois de septembre lorsque Liquid Instruments prévoit de lancer une fonctionnalité qui donnera à Moku:Pro la possibilité d’exécuter plusieurs instruments conjointement les uns avec les autres et les instruments échangeables à chaud à l’intérieur et à l’extérieur. Dans ce mode multi-instruments, les instruments peuvent être combinés et connectés pour former des pipelines sophistiqués de traitement des signaux. En septembre, la sortie d’un nouvel outil basé sur le cloud qui permettra aux utilisateurs de programmer directement le FPGA de Moku:Pro est également prévue. Grâce à cette capacité, les utilisateurs peuvent mettre en œuvre des algorithmes de traitement de signal uniques et créer leurs propres instruments personnalisés, ce qui permettra d’élargir davantage l’écart avec le matériel conventionnel.

Caractéristiques de Moku:Pro

  • 4 entrées et sorties analogiques
  • Entrée ADC mélangée (10 bits+18 bits) pour les applications à faible bruit et large bande passante
  • Taux d’échantillonnage de 5 GSa/s (1 canal), 1,25 GSa/s (4 canaux)
  • 9 instruments intégrés, y compris un amplificateur à détection synchrone DC-600 MHz
  • SSD 120 Go pour un stockage à haute vitesse à bord
  • Prise en charge API pour Python et MATLAB
  • À partir de 12 000 $ pour la configuration de base, allant jusqu’à 20 000 $ pour la suite complète.

Une histoire de réussite 
L’équipe de direction technique de Liquid Instruments apporte une expertise approfondie dans les mesures complexes avec l’expérience de l’Université nationale australienne, du Max Planck Institute, de Lockheed Martin, de Caltech et du Jet Propulsion Laboratory de la NASA. Moku:Pro étend la gamme de solutions définies par logiciel de Moku:Lab, une plateforme de douze instruments pour la recherche, et, plus récemment, Moku:Go, une solution de laboratoire complète et portable pour l’enseignement de premier cycle.

Pour tout complément d’information sur Moku:Pro, veuillez consulter le site : liquidinstruments.com

À propos de Liquid Instruments
Liquid Instruments est un leader des instruments de précision conçus par logiciel et révolutionne la manière dont les étudiants, les ingénieurs et les scientifiques apprennent, travaillent et découvrent. Sa gamme de solutions matérielles et logicielles tire parti de la puissance de calcul des FPGA modernes pour créer des instruments hautement personnalisables afin de contrôler les expériences et acquérir et analyser des données. La propriété intellectuelle de l’équipe en matière de matériel informatique défini par logiciel permet aux produits de Moku d’être reconfigurés dynamiquement sur le terrain, servant une large gamme de situations expérimentales et de contrôle des processus en constante évolution. Pour tout complément d’informations, rendez-vous sur https://liquidinstruments.com.

Le projet a été financé par le gouvernement australien. Liquid Instruments tient à remercier le financement et le soutien du gouvernement du Commonwealth australien dans le cadre du programme CRC-P administré par le ministère de l’Innovation industrielle et des Sciences.

Contact auprès des médias
Codeword pour Liquid Instruments
liquidinstruments@codewordagency.com
801-703-4092

Les photographies accompagnant ce communiqué sont disponibles sur :

https://www.globenewswire.com/NewsRoom/AttachmentNg/37cb06a3-2242-4fe9-b6d2-0243a826051f

https://www.globenewswire.com/NewsRoom/AttachmentNg/8e84cd5f-7bf1-4276-9950-f57a12cfac19

Posted on

Vytelle Releases Public Feed Efficiency Database

KANSAS CITY, Missouri, June 22, 2021 (GLOBE NEWSWIRE) — Vytelle, with their network partners, announce the release of the Top 150 Proven Bulls. These high accuracy bulls have risen to the top of more than 81,000 animals of 25 different breeds and more than 262,000 residual feed intake (RFI) EPDs.

“There are two high-stake producer decisions that drive genetic progress in the global cattle industry: mating selection and reproduction method. By publicly sharing this list of feed efficient bulls, we’re able to assist cattle producers in identifying elite animals that drive a more accurate mating selection,” said Kerryann Kocher, Chief Executive Officer for Vytelle. “Producers can accelerate genetic progress to meet the global demand for high-quality and nutritious protein by utilizing the most modern hormone-free, in vitro fertilization to multiply offspring from their elite-performing animals.

The 2021 Top 150 Bulls list was compiled using data collected by Vytelle SENSE systems and Vytelle INSIGHT analytics services, formerly known as GrowSafe Systems. All tested animals include at least three generations of pedigrees and all animals must have at least a 0.6 accuracy rating on their RFI EPD to be eligible for the list. Each phenotyped animal strengthens the database providing producers insight to make profit-bearing decisions regarding selection for feed efficiency and performance. With the permission of each network member, Vytelle shares this information publicly to collectively advance feed efficiency improvements across the industry.

“Feed is 70 percent of a beef producer’s total production costs,” said Lisa Rumsfeld, Vice President of International Commercial Operation for Vytelle. “Whether breeders are looking to impact their direct feed cost, achieve marketing premiums or underpin methane emissions reduction claims with evidence-based metrics this database offers selection possibilities across breeds globally.”

Phenotypic data is captured through the use of Vytelle SENSE systems. The Feed Intake Nodes measure feed disappearance every second an animal is feeding, each time an animal feeds, to a 10-gram resolution. The In-Pen Weighing Position measures individual animal partial body weight and growth. It weighs every second an animal is standing at the water trough, which can equate up to 450 weights a day.

To find the full listing of the 2021 Top 150 Proven Bulls, visit https://vytelle.com/breeding-values/.

About Vytelle

Vytelle is a precision livestock company reshaping how cattle producers worldwide optimize their herds. Through Vytelle’s integrated technology platform, generations of genetic gains can be made in just a few years. This allows producers to sustainably deliver more protein with fewer inputs, helping to ensure meat and milk are viable, competitive food choices for future generations.

Attachment

Danielle Starr
Vytelle
danielle.starr@vytelle.com
Posted on

Huobi Launches Bonus Point Campaign with $18,000 Prize Pool for P2P Advertisers

GIBRALTAR, June 21, 2021 /PRNewswire/ — Huobi Global, one of the world’s leading digital asset exchanges, announced last week the launch of its bonus point campaign for users from India, Russia, and Nigeria. Aiming at improving the liquidity of its P2P Market, the launch of this campaign offers users multiple choices while endowing advertisers with more benefits.

“Professional players represented by large institutions and listed companies are continuing to enter the digital assets market in recent years. At the same time, there are still many people in the world who have not been able to enjoy the benefits brought about by the development of this industry. As the first link into the crypto space, peer-to-peer market plays a decisive role in connecting fiat and cryptocurrency,” stated Ciara Sun, Vice President of Huobi Global Markets.

In addition to sharing the prize pool, advertisers participating in the event could also upgrade to “Verified” advertisers with a “V” symbol next to their names. For each region, only 20 advertisers would be selected to join in the campaign. Satisfying different conditions such as posting time, payment method, order completion rate, and trading volume are methods for advertisers to be able to obtain corresponding points which could then be redeemed for rewards.

In most normal circumstances, gaining access to the points can be easy for participants. For instance, if an advertiser’s USDT selling price ranks TOP 10 on another platform, he/she will be able to obtain three points. If the advertiser posts two ads with at least one of them resulting in a sale of 500 USDT, he/she earns two points. Other conditions such as supporting local bank cards, having order completion rates greater than 85%, or exceeding 150-hour advertisement posting time will count as 1 point. Only 6 points, however, are required for a reward and the highest score of 10 points could be used to redeem 300 HUSD.

“We’ve been committed to providing institutional and retail users with a safe, stable, and user-friendly trading experience in a compliant manner. By offering users more choices in relation to pricing and advertising, we can greatly reduce their time and cost for trading. This will, in turn, help us establish a sound ecosystem,” added Ciara.

To participate in the campaign, users from India, Russia, and Nigeria are required to register through an exclusive link, complete advanced verification, and enable phone authentication.

About Huobi Group
Huobi Group is a world leading blockchain and cryptocurrency infrastructure provider with a financial product suite that includes the largest digital asset exchange by liquidity and real-trading volume. Trusted by users in over 170 countries, the Huobi platform is dedicated to improving financial freedom and inclusive access for all users. Huobi boasts an unmatched portfolio of crypto product offerings. This includes trading and financial products, cryptocurrency and blockchain financial infrastructure solutions, education, data and research, social welfare, investment, and incubation. We are always continuing to innovate on our future horizon.

Posted on

Centrient Pharmaceuticals boosting statins API manufacturing capacity

Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) —

Summary:

  • Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India.
  • With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins.
  • Centrient Pharmaceuticals’ statins are one of the most sustainably produced in the industry by eliminating harmful solvents, generating less waste, and a reduced carbon footprint of 32% as compared to traditional manufacturers.
  • Using backward integrated manufacturing methods, and dedicated production facilities, Centrient Pharmaceuticals is able to offer its customers security of supply.

Centrient Pharmaceuticals (“Centrient”), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed, the company will double its statins production capacity. This will enable Centrient to meet growing demand for its sustainably manufactured Atorvastatin and Rosuvastatin Active Pharmaceutical Ingredients (APIs).

Statins are currently the most prescribed drug class globally for the treatment of high cholesterol and cardiovascular diseases and are among the top-selling drugs worldwide. The markets for Atorvastatin and Rosuvastatin in particular, has shown steady growth in the past years, as a result of the continued global prevalence of high cholesterol issues, replacement of older generation statins, and genericization of the market.

Starting almost a decade ago, Centrient has grown today into one of the leading statin API suppliers worldwide, servicing large pharma companies around the globe.

Next to high-quality features like long shelf life and large batch sizes, the company offers security of supply to customers through its dedicated statins production facility and backward integration. Being backward integrated, Centrient is independent from external imports of starting materials. Its enzymatic route of synthesis and patented technology minimise the use of harmful solvents, generate less waste, and reduce the company’s carbon footprint by 32% as compared to traditional manufacturers.

The news of the facility expansion follows major milestones on statins that the company reached in the past years. In 2012, under the name of DSM Sinochem Pharmaceuticals, it was the first pharmaceutical manufacturer worldwide to offer generic Atorvastatin APIs under a Certificate of Suitability to the Monograph of the European Pharmacopoeia (CEP). Since 2014, it has produced the unique Atorvastatin APIs in its state-of-the-art facility in Toansa, India for third-party customers.

In addition, the company was one of the first three companies worldwide that started to offer generic Rosuvastatin APIs under CEP in 2016. Two years later, the first generic Rosuvastatin and Atorvastatin finished dosage forms were launched in Western Europe.

“With the doubling of our production capacity, we demonstrate our commitment to maintain our leadership position in line with our strategy and to continue supporting our customers’ business growth. Guided by our brand promise of Quality, Reliability, and Sustainability, Centrient’s Rosuvastatin and Atorvastatin offer superior performance in all three areas to the benefit of our customers and the environment.”, says Frans Vlaar, Chief Commercial Officer at Centrient.

Ground breaking of the new manufacturing unit started at the end of 2019 and commercial supplies from the new unit will start in mid-2021. With the new manufacturing line being operational and doubling the production capacity, Centrient will be even better positioned to secure supply, meeting the growing demand from customers and helping to improve the lives of patients who are in need of these medicine.

“We are extremely proud that we have been able to complete this project in a timely way given the challenges of executing such a complex project in the midst of the COVID pandemic,” says Jim McPherson, Chief Quality & Technical Operations Officer. “It reinforces our absolute commitment to meet the expectations of our customers as a partner of choice – delivering reliable and secure supply using leading sustainable technologies. The facility incorporates design features that allow further improvements in GMP and energy utilization, and enable greater automation for improved process control.”

———————————————————————————————————————————–


About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and antifungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.

We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 2200 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance.

Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, Egypt, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.

For more information please visit www.centrient.com or contact Centrient Pharmaceuticals Corporate Communications, Alice Beijersbergen, Director Branding & Communications. E-Mail: alice.beijersbergen@centrient.com.

Forward-looking statements
This press release may contain forward-looking statements with respect to Centrient Pharmaceuticals’ future financial performance and position. Such statements are based on current expectations, estimates and projections of Centrient and information currently available to the company. Centrient cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. Centrient has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is governing.

Alice Beijersbergen
Centrient Pharmaceuticals
alice.beijersbergen@centrient.com
Proudly powered by WordPress